ianalumab
novartis
['ianalumab', 'lupus', 'novartis']
 the lra and our affiliate lupus therapeutics are pleased to share that data presented at #eular2023 - showed positive effectiveness and safety results with ianalumab, a potential treatment in development for systemic lupus erythematosus.
The Lupus Research Alliance is the world’s largest private funder of lupus research. Together with your help, we will conquer lupus.